Skip to content

Development of deuterium metabolic imaging to map body biochemistry with MRI

Development of deuterium metabolic imaging to map body biochemistry with MRI - BodyDMI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56442
Enrollment
20
Registered
2021-02-11
Start date
2023-04-12
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2 type 2 diabetes Type 2 diabetes

Interventions

N.A.

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All subjects: • Age > 40 and younger than 70 years  • Sex: male • Ability and willing to give informed consent • Ability to follow test instructions • Sufficient understanding of the Dutch language Healthy control subjects: • BMI: 20-25 kg/m2 Type 2 diabetes patients: • Patients diagnosed with type 2 diabetes for at least 1 year• Indicated for initiation of standard-of-care therapy with semaglutide, with no prior use of GLP-1 receptor agonists • BMI: 27-35 kg/m2

Exclusion criteria

Exclusion criteria: All subjects: • Contra-indications to MRI examination according to 7T MRI screening guideline  of the UMC Utrecht • An average alcohol consumption of >21 standard drinks per week • Abnormal liver function (fibrosis) Type 2 diabetes patients: • Known causes of hepatic steatosis other than non-alcoholic fatty liver  disease

Design outcomes

Primary

MeasureTime frame
The main study parameters are 3D DMI measurements of hepatic carbohydrate of healthy volunteers and type 2 diabetes patients. Specifically we will determine rates of glucose uptake and metabolism.

Countries

Netherlands

Contacts

Public ContactJ.J. Prompers

Universitair Medisch Centrum Utrecht

BodyDMI@umcutrecht.nl+31 88 75 56674

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026